18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial. [electronic resource]
Producer: 20100419Description: 567-74 p. digitalISSN:- 1535-5667
- Canada
- Coronary Artery Disease -- diagnostic imaging
- Female
- Fluorodeoxyglucose F18
- Heart -- diagnostic imaging
- Heart Failure -- diagnostic imaging
- Humans
- Male
- Middle Aged
- Myocardial Revascularization
- Patient Care Team
- Positron-Emission Tomography
- Professional Competence
- Radiopharmaceuticals
- Randomized Controlled Trials as Topic
- Survival Analysis
- Tissue Survival
- Ventricular Dysfunction, Left -- diagnostic imaging
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.